Middle East Healthcare Company (4009.SR) — Income statement
Revenue, gross profit, operating income, net income, and EPS for Middle East Healthcare Company — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 3,103↑7.6% | 2,883↑8.7% | 2,653↑23.3% | 2,152↑14.9% | 1,873 | |
| Cost of Revenue | 1,943↑9.8% | 1,769↑7.2% | 1,649↑12.1% | 1,472↑16.4% | 1,264 | |
| Gross Profit | 1,160↑4.1% | 1,114↑11.0% | 1,004↑47.6% | 680↑11.8% | 608 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00↓100.0% | 145↓76.3% | 610↑626.7% | 84↓18.0% | 102 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 73↑43.3% | 51↑68.1% | 30↓33.9% | 46 | |
| SG&A Expenses | 0.00↓100.0% | 218↓67.0% | 661↑478.3% | 114↓22.9% | 148 | |
| Other Expenses | 773↑69.8% | 455 | 0.00↓100.0% | 421↑5.9% | 397 | |
| Operating Expenses | 773↑14.8% | 673↑1.8% | 661↑23.6% | 535↓1.9% | 546 | |
| Total Costs & Expenses | 2,715↑11.2% | 2,442↑5.7% | 2,311↑15.1% | 2,007↑10.9% | 1,810 | |
| Operating Results | ||||||
| Operating Income | 391↓11.4% | 441↑28.7% | 342↑144.0% | 140↑158.7% | 54 | |
| Depreciation & Amortization | 246↑13.5% | 217↑14.2% | 190↑30.0% | 146↑3.2% | 141 | |
| EBITDA | 637↓14.8% | 747↑40.0% | 534↑86.5% | 286↑46.3% | 196 | |
| EBIT | 391↓26.4% | 531↑54.2% | 344↑145.2% | 140↑158.7% | 54 | |
| Interest & Other Income | ||||||
| Net Interest Income | -202↑11.2% | -227↓48.5% | -153↓109.4% | -73↓32.2% | -55 | |
| Interest Income | 0.00↑100.0% | -3↓140.2% | 7↓90.0% | 66↑58.9% | 42 | |
| Interest Expense | 202↓10.2% | 225↑40.7% | 160↑142.2% | 66↑58.9% | 42 | |
| Non-Operating Income | 0.00↑100.0% | -90↓5453.0% | -2 | 0.00 | 0.00 | |
| Other Income / Expenses | -65↑50.2% | -131↑7.2% | -141↓138.3% | -59↓68.9% | -35 | |
| Income Before Tax | 325↑4.9% | 310↑53.8% | 202↑148.2% | 81↑322.3% | 19 | |
| Income Tax Expense | 16↓39.0% | 26↑46.1% | 18↑87.0% | 10↑28.2% | 8 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 309↑8.8% | 284↑54.9% | 184↑156.5% | 72↑510.3% | 12 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 302↑7.0% | 282↑56.5% | 180↑139.7% | 75↑540.8% | 12 | |
| Bottom-Line Net Income | 302↑7.0% | 282↑56.5% | 180↑139.7% | 75↑337.1% | 17 | |
| EPS (Basic) | 3.28↑7.2% | 3.06↑56.1% | 1.96↑139.0% | 0.82↑530.8% | 0.13 | |
| EPS (Diluted) | 3.28↑7.2% | 3.06↑56.1% | 1.96↑139.0% | 0.82↑530.8% | 0.13 | |
| Weighted Average Shares | 92↓0.0% | 92↑0.0% | 92↑0.0% | 92↑0.0% | 92 | |
| Weighted Average Diluted Shares | 92↓0.0% | 92↑0.0% | 92↑0.0% | 92↑0.0% | 92 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.